| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Median Arcuate Ligament Syndrome | 7 | 2023 | 23 | 2.480 |
Why?
|
| Peripheral Arterial Disease | 6 | 2024 | 110 | 1.620 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2015 | 135 | 1.330 |
Why?
|
| Abdominal Pain | 6 | 2023 | 148 | 1.260 |
Why?
|
| Celiac Artery | 4 | 2023 | 26 | 1.210 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2015 | 234 | 1.160 |
Why?
|
| Vascular Surgical Procedures | 8 | 2018 | 166 | 1.110 |
Why?
|
| Tunica Intima | 5 | 2015 | 61 | 1.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 14 | 2018 | 246 | 0.950 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 211 | 0.910 |
Why?
|
| Lower Extremity | 4 | 2024 | 104 | 0.900 |
Why?
|
| Carotid Stenosis | 7 | 2012 | 116 | 0.880 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2016 | 107 | 0.830 |
Why?
|
| Herpesvirus 1, Human | 4 | 2015 | 210 | 0.810 |
Why?
|
| Stents | 7 | 2018 | 432 | 0.800 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 399 | 0.730 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1787 | 0.710 |
Why?
|
| Carotid Artery, Internal | 4 | 2012 | 75 | 0.660 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2018 | 125 | 0.640 |
Why?
|
| Endarterectomy, Carotid | 4 | 2012 | 74 | 0.630 |
Why?
|
| Chronic Pain | 3 | 2018 | 203 | 0.610 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 170 | 0.600 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 91 | 0.540 |
Why?
|
| Hyperplasia | 6 | 2015 | 148 | 0.520 |
Why?
|
| Apoptosis | 3 | 2008 | 1750 | 0.520 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2019 | 42 | 0.510 |
Why?
|
| Mental Disorders | 2 | 2018 | 483 | 0.500 |
Why?
|
| Quality of Life | 4 | 2021 | 1892 | 0.460 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2013 | 56 | 0.460 |
Why?
|
| Laparoscopy | 4 | 2018 | 792 | 0.460 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2018 | 92 | 0.450 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 335 | 0.450 |
Why?
|
| Rabbits | 9 | 2015 | 581 | 0.400 |
Why?
|
| Ligaments | 1 | 2013 | 33 | 0.400 |
Why?
|
| Simplexvirus | 2 | 2012 | 66 | 0.390 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 66 | 0.380 |
Why?
|
| Aortic Diseases | 3 | 2009 | 88 | 0.370 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2012 | 41 | 0.360 |
Why?
|
| Coronary Disease | 1 | 2013 | 227 | 0.350 |
Why?
|
| Iliac Artery | 2 | 2009 | 44 | 0.340 |
Why?
|
| Coronary Vessels | 1 | 2013 | 178 | 0.340 |
Why?
|
| Risk Factors | 10 | 2024 | 6220 | 0.340 |
Why?
|
| Humans | 53 | 2024 | 97913 | 0.330 |
Why?
|
| Carotid Arteries | 1 | 2012 | 132 | 0.330 |
Why?
|
| Mass Screening | 1 | 2016 | 745 | 0.330 |
Why?
|
| Leg | 5 | 2003 | 145 | 0.330 |
Why?
|
| Male | 41 | 2024 | 46983 | 0.330 |
Why?
|
| Aneurysm, False | 2 | 2007 | 52 | 0.310 |
Why?
|
| Treatment Outcome | 18 | 2018 | 9689 | 0.310 |
Why?
|
| Angioplasty | 2 | 2007 | 68 | 0.300 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 22 | 0.290 |
Why?
|
| Veins | 5 | 2009 | 87 | 0.280 |
Why?
|
| Calcinosis | 1 | 2009 | 220 | 0.270 |
Why?
|
| Endoleak | 3 | 2019 | 45 | 0.270 |
Why?
|
| Aneurysm, Infected | 1 | 2007 | 14 | 0.270 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2018 | 255 | 0.270 |
Why?
|
| Brachial Artery | 1 | 2007 | 37 | 0.260 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 74 | 0.260 |
Why?
|
| Exercise Therapy | 2 | 2018 | 96 | 0.260 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2007 | 76 | 0.250 |
Why?
|
| Nicotine | 1 | 2008 | 218 | 0.240 |
Why?
|
| Retrospective Studies | 16 | 2024 | 10922 | 0.240 |
Why?
|
| Female | 30 | 2024 | 51441 | 0.230 |
Why?
|
| Aged | 22 | 2024 | 21703 | 0.230 |
Why?
|
| Middle Aged | 23 | 2024 | 29366 | 0.230 |
Why?
|
| Hemodynamics | 5 | 2008 | 746 | 0.230 |
Why?
|
| Vascular Patency | 8 | 2009 | 123 | 0.220 |
Why?
|
| Adolescent | 9 | 2020 | 10078 | 0.220 |
Why?
|
| Time Factors | 11 | 2018 | 5566 | 0.210 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 164 | 0.210 |
Why?
|
| Thoracoscopy | 1 | 2003 | 21 | 0.200 |
Why?
|
| Genetic Vectors | 2 | 2003 | 426 | 0.200 |
Why?
|
| Thymectomy | 1 | 2003 | 32 | 0.200 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 142 | 0.200 |
Why?
|
| Treatment Failure | 1 | 2024 | 300 | 0.200 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 7371 | 0.190 |
Why?
|
| Myasthenia Gravis | 1 | 2003 | 85 | 0.190 |
Why?
|
| Ischemia | 5 | 2009 | 261 | 0.190 |
Why?
|
| Saphenous Vein | 5 | 2002 | 61 | 0.190 |
Why?
|
| Blood Flow Velocity | 6 | 2019 | 179 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2024 | 2582 | 0.180 |
Why?
|
| Logistic Models | 2 | 2024 | 1274 | 0.180 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 43 | 0.180 |
Why?
|
| Comorbidity | 4 | 2018 | 1031 | 0.170 |
Why?
|
| Reoperation | 4 | 2013 | 725 | 0.170 |
Why?
|
| Limb Salvage | 3 | 2009 | 42 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2013 | 2663 | 0.160 |
Why?
|
| Preoperative Care | 2 | 2013 | 418 | 0.160 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 47 | 0.160 |
Why?
|
| Walking | 2 | 2018 | 114 | 0.160 |
Why?
|
| Foreign Bodies | 1 | 2020 | 61 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 153 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 140 | 0.150 |
Why?
|
| Child | 5 | 2019 | 7687 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2001 | 373 | 0.150 |
Why?
|
| Child Mortality | 1 | 2019 | 9 | 0.150 |
Why?
|
| Environmental Health | 1 | 2019 | 12 | 0.150 |
Why?
|
| Child Health | 1 | 2019 | 15 | 0.150 |
Why?
|
| Public Health | 1 | 2020 | 161 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2018 | 164 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 36 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 4020 | 0.140 |
Why?
|
| Home Nursing | 1 | 2018 | 17 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 67 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 151 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2008 | 161 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 114 | 0.130 |
Why?
|
| Wearable Electronic Devices | 1 | 2018 | 45 | 0.130 |
Why?
|
| Femoral Artery | 3 | 2009 | 96 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 902 | 0.120 |
Why?
|
| Pain Measurement | 1 | 2018 | 401 | 0.120 |
Why?
|
| Thrombosis | 2 | 2014 | 317 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 186 | 0.120 |
Why?
|
| Mental Health | 1 | 2018 | 219 | 0.120 |
Why?
|
| Ecosystem | 1 | 2020 | 424 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 360 | 0.120 |
Why?
|
| Regional Blood Flow | 4 | 2018 | 194 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 31 | 0.120 |
Why?
|
| Stress, Mechanical | 3 | 2008 | 251 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 939 | 0.110 |
Why?
|
| Aneurysm, Ruptured | 2 | 2006 | 80 | 0.110 |
Why?
|
| Animals | 10 | 2015 | 28864 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2018 | 4815 | 0.110 |
Why?
|
| Carotid Artery, Common | 3 | 2008 | 28 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2013 | 7 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 920 | 0.100 |
Why?
|
| Adult | 10 | 2018 | 29498 | 0.100 |
Why?
|
| Jugular Veins | 3 | 2005 | 65 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2013 | 176 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 142 | 0.100 |
Why?
|
| Diaphragm | 1 | 2013 | 76 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 125 | 0.100 |
Why?
|
| Mutation | 4 | 2012 | 4389 | 0.090 |
Why?
|
| Leptospirosis | 1 | 2012 | 3 | 0.090 |
Why?
|
| Radiography | 4 | 2007 | 760 | 0.090 |
Why?
|
| Disease Progression | 2 | 2015 | 1607 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2002 | 98 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 64 | 0.090 |
Why?
|
| Aortography | 2 | 2009 | 59 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 814 | 0.090 |
Why?
|
| Lumbosacral Plexus | 1 | 2011 | 10 | 0.080 |
Why?
|
| Pediatrics | 1 | 2016 | 420 | 0.080 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 20 | 0.080 |
Why?
|
| ras Proteins | 1 | 2012 | 137 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 157 | 0.080 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 319 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 43 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 2011 | 39 | 0.080 |
Why?
|
| Carotid Artery, External | 2 | 2008 | 9 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 983 | 0.080 |
Why?
|
| Young Adult | 3 | 2018 | 7490 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2854 | 0.080 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 78 | 0.080 |
Why?
|
| Environment | 1 | 2012 | 233 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 511 | 0.080 |
Why?
|
| Research Design | 1 | 2014 | 658 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1008 | 0.080 |
Why?
|
| Atherectomy | 1 | 2009 | 4 | 0.080 |
Why?
|
| Rupture | 1 | 2009 | 58 | 0.080 |
Why?
|
| Shear Strength | 1 | 2008 | 17 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 122 | 0.070 |
Why?
|
| Recurrence | 2 | 2002 | 1251 | 0.070 |
Why?
|
| Popliteal Artery | 2 | 2006 | 32 | 0.070 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 1782 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 3 | 2002 | 72 | 0.070 |
Why?
|
| Ligation | 1 | 2007 | 55 | 0.070 |
Why?
|
| Cell Line | 1 | 2012 | 2482 | 0.070 |
Why?
|
| Collateral Circulation | 1 | 2007 | 37 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 780 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 283 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 125 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2003 | 1527 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 100 | 0.060 |
Why?
|
| Arteries | 1 | 2007 | 171 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2006 | 14 | 0.060 |
Why?
|
| Homeostasis | 1 | 2008 | 474 | 0.060 |
Why?
|
| Robotics | 1 | 2008 | 272 | 0.050 |
Why?
|
| Pulsatile Flow | 2 | 2001 | 49 | 0.050 |
Why?
|
| Smoking | 1 | 2008 | 673 | 0.050 |
Why?
|
| Models, Animal | 2 | 2001 | 282 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2003 | 22 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2002 | 29 | 0.050 |
Why?
|
| Viscera | 1 | 2002 | 19 | 0.050 |
Why?
|
| Stroke | 1 | 2012 | 1152 | 0.050 |
Why?
|
| Iliac Aneurysm | 1 | 2002 | 9 | 0.050 |
Why?
|
| Radial Artery | 1 | 2002 | 40 | 0.050 |
Why?
|
| Embolism | 1 | 2002 | 32 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2018 | 307 | 0.050 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 11 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 120 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 96 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 218 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 102 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 120 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2002 | 678 | 0.040 |
Why?
|
| Hemorheology | 1 | 2001 | 8 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 107 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 3615 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 155 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2002 | 236 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2020 | 71 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1995 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 295 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2002 | 910 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 883 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 445 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2001 | 238 | 0.040 |
Why?
|
| Heart Rate | 1 | 2002 | 535 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2001 | 193 | 0.040 |
Why?
|
| Conservation of Natural Resources | 1 | 2020 | 102 | 0.040 |
Why?
|
| Bhutan | 1 | 2019 | 4 | 0.040 |
Why?
|
| Sri Lanka | 1 | 2019 | 4 | 0.040 |
Why?
|
| Vietnam | 1 | 2019 | 16 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2000 | 117 | 0.040 |
Why?
|
| Nepal | 1 | 2019 | 17 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2019 | 22 | 0.040 |
Why?
|
| Sanitation | 1 | 2019 | 6 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 1138 | 0.040 |
Why?
|
| Thailand | 1 | 2019 | 69 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 72 | 0.040 |
Why?
|
| Child Nutrition Disorders | 1 | 2019 | 13 | 0.040 |
Why?
|
| Chicago | 3 | 2015 | 1511 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2019 | 64 | 0.040 |
Why?
|
| Pesticides | 1 | 2019 | 33 | 0.040 |
Why?
|
| India | 1 | 2019 | 150 | 0.040 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Drinking Water | 1 | 2019 | 80 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 166 | 0.030 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.030 |
Why?
|
| Bangladesh | 1 | 2019 | 361 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 2016 | 0.030 |
Why?
|
| Telephone | 1 | 2018 | 43 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 2017 | 20 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 386 | 0.030 |
Why?
|
| Walk Test | 1 | 2017 | 38 | 0.030 |
Why?
|
| Biodiversity | 1 | 2020 | 252 | 0.030 |
Why?
|
| Pressure | 3 | 2002 | 173 | 0.030 |
Why?
|
| Air Pollution | 1 | 2019 | 118 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 190 | 0.030 |
Why?
|
| Analgesics | 1 | 2018 | 131 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 3014 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2018 | 245 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 355 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 508 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 367 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 2010 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1947 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 304 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2019 | 404 | 0.030 |
Why?
|
| Stem Cells | 1 | 2017 | 395 | 0.030 |
Why?
|
| Telemedicine | 1 | 2018 | 249 | 0.030 |
Why?
|
| Rupture, Spontaneous | 2 | 2006 | 43 | 0.030 |
Why?
|
| Hospitalization | 1 | 2000 | 985 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1750 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2002 | 2676 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 743 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 2525 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 1114 | 0.020 |
Why?
|
| American Samoa | 1 | 2012 | 1 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 29 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 58 | 0.020 |
Why?
|
| Infant | 1 | 2019 | 3325 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 4000 | 0.020 |
Why?
|
| Back Pain | 1 | 2011 | 76 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 76 | 0.020 |
Why?
|
| Constipation | 1 | 2011 | 68 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 726 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4105 | 0.020 |
Why?
|
| Length of Stay | 2 | 2002 | 875 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 194 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 121 | 0.020 |
Why?
|
| Vascular Fistula | 1 | 2006 | 12 | 0.020 |
Why?
|
| Respiratory Tract Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
| Tracheal Diseases | 1 | 2006 | 14 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2006 | 47 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2785 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2006 | 48 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 795 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 2033 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2570 | 0.010 |
Why?
|
| Critical Illness | 1 | 2009 | 424 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 3207 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 161 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 161 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 188 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2003 | 13 | 0.010 |
Why?
|
| Inguinal Canal | 1 | 2003 | 6 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 264 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2002 | 13 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2003 | 42 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 111 | 0.010 |
Why?
|
| Rheology | 1 | 2002 | 38 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 993 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 138 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 123 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2002 | 31 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 19 | 0.010 |
Why?
|
| Time | 1 | 2002 | 80 | 0.010 |
Why?
|
| Femoral Vein | 1 | 2002 | 42 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 233 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2002 | 57 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 230 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 226 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 945 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 263 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2002 | 250 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 271 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 440 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 1014 | 0.010 |
Why?
|
| Life Tables | 1 | 2000 | 46 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 340 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 288 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 689 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 155 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 512 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 889 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 537 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3605 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2000 | 395 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 802 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2002 | 381 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2033 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 994 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1814 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2440 | 0.010 |
Why?
|
| Hypertension | 1 | 2001 | 778 | 0.010 |
Why?
|